Lumaegis
Private Company
Total funding raised: $4.5M
Overview
Lumaegis is a private, pre-revenue medical technology company developing the RadBox™, a novel system for surgical instrument sterilization. Operating in the drug delivery and small molecule sectors, the company aims to address critical challenges in infection control within surgical environments. Based in San Diego and founded in 2018, it is currently in a pre-commercial stage, with its technology not yet available for sale or distribution in the USA. The company's value proposition centers on enhancing safety, efficacy, and sustainability in sterile processing.
Technology Platform
RadBox™ system for surgical instrument sterilization, likely integrating a physical device with radiative (light-based) and/or small molecule-based disinfection technology.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes against large, established medical device companies like STERIS, Getinge, and Johnson & Johnson (ASP) that dominate the hospital sterilization equipment market. Also competes with alternative low-temperature technologies like hydrogen peroxide plasma and ozone systems. Differentiation must be clear on speed, instrument compatibility, and sustainability.